AMICUS THERAPEUTICS, INC. — Director's Dealing 2014

Jul 8, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2014-07-07

Reporting Person: Doshi Dipal (SVP Business Planning & Dev)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-07	Common stock	A	25000	$0.00	Acquired	25000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-07	Stock Options (right to buy)	$3.90	A	125000	Acquired	2024-07-07	Common Stock (125000)	Direct

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on July 7, 2015. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on August 1, 2015, with the final installment vesting on July 1, 2018.